Land: Australia
Språk: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
cetirizine hydrochloride, Quantity: 10 mg
Pharmacor Pty Ltd
cetirizine hydrochloride
Tablet, film coated
Excipient Ingredients: purified water; croscarmellose sodium; colloidal anhydrous silica; lactose monohydrate; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400
Oral
10's, 30's, 100's, 70's, 50's
(S2) Pharmacy Medicine
Seasonal Allergic Rhinitis: Cetirizine is indicated for the relief of symptoms associated with seasonal allergic rhinitis (hay fever) in adults and children 6 years and over. Symptoms treated effectively include sneezing, rhinorrhea, post-nasal discharge, nasal pruritus, ocular pruritus, tearing and redness of the eyes., Perennial allergic rhinitis: Cetirizine is indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children 6 years and over. Symptoms treated effectively include sneezing, rhinorrhea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing., Chronic idiopathic urticaria: Cetirizine is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years and over. It significantly reduces the occurrence, severity and duration of hives and markedly reduces pruritus. As with other antihistamines, patients should be advised to seek medical advice about the possibility that their urticaria is associated with ingestion of certain foods.
Visual Identification: White to off white coloured, oblong shaped, film coated tablets having ?10? debossed on one side and break line on other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2015-12-15